Mark J. O’Connor
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Oncology top 10%
- PARP inhibition in cancer therapy
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 12
- PARP inhibition in cancer therapy 10
-
- CRISPR and Genetic Engineering 4
- DNA Repair Mechanisms 2
- Co-authors
- Darren Hodgson (3 shared papers)Xiaolu Yin (2 shared papers)Yung‐Jue Bang (2 shared papers)Woo Ho Kim (2 shared papers)Tony R. Merriman (1 shared paper)Chio Yokose (1 shared paper)Hyon K. Choi (1 shared paper)David B. Mount (1 shared paper)
- Journals
- Cancer Research (4 papers)Journal of Clinical Oncology (2 papers)Prehospital Emergency Care (2 papers)Psycho-Oncology (1 paper)Current Diabetes Reports (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Mark J. O’Connor
34 papers receiving 841 citations
Peers
Comparison fields: 5 of 92
- Nephrology 95
- Oncology 270
- Gastroenterology 26
- Anesthesiology and Pain Medicine 22
- Cardiology and Cardiovascular Medicine 83
Countries citing papers authored by Mark J. O’Connor
This map shows the geographic impact of Mark J. O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. O’Connor more than expected).
Fields of papers citing papers by Mark J. O’Connor
This network shows the impact of papers produced by Mark J. O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. O’Connor. The network helps show where Mark J. O’Connor may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. O’Connor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 222 | |
| 2 | 2021 | 110 | |
| 3 | 2014 | 79 | |
| 4 | 2017 | 60 | |
| 5 | 2013 | 49 | |
| 6 | 2021 | 43 | |
| 7 | 2011 | 37 | |
| 8 | 2009 | 27 | |
| 9 | 2024 | 25 | |
| 10 | 2020 | 24 | |
| 11 | 2013 | 20 | |
| 12 | 2019 | 19 | |
| 13 | 2018 | 16 | |
| 14 | 2020 | 14 | |
| 15 | 2021 | 14 | |
| 16 | 2010 | 13 | |
| 17 | 2017 | 13 | |
| 18 | 2018 | 12 | |
| 19 | 2003 | 10 | |
| 20 | Patients Hospitalised with an Acute Exacerbation of COPD: Is There a Need for a Discharge Bundle of Care? | 2015 | 8 |
About Mark J. O’Connor
Mark J. O’Connor is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging, having authored 35 papers that have together received 862 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (10 papers), CRISPR and Genetic Engineering (4 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers), Advanced Breast Cancer Therapies (3 papers), Diabetes Management and Research (2 papers), DNA Repair Mechanisms (2 papers), T-cell and B-cell Immunology (2 papers) and Radiation Therapy and Dosimetry (2 papers). The work is most often cited by research in Nephrology (95 citations), Oncology (270 citations), Gastroenterology (26 citations), Anesthesiology and Pain Medicine (22 citations) and Cardiology and Cardiovascular Medicine (83 citations). Mark J. O’Connor has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Darren Hodgson, Xiaolu Yin, Yung‐Jue Bang, Woo Ho Kim, Tony R. Merriman, Chio Yokose, Hyon K. Choi, David B. Mount, Natalie McCormick and Keun‐Wook Lee. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Prehospital Emergency Care, Psycho-Oncology and Current Diabetes Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.